Buy or sell DoubleRainbow Biosciences stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

DoubleRainbow Biosciences Stock

DoubleRainbow Biosciences develops transformative technologies to unleash the power of chemistry.

About DoubleRainbow Biosciences Stock

DoubleRainbow Biosciences develops transformative technologies to unleash the power of chemistry from the natural world to benefit people’s lives. Rooted in the mechanistic understanding of specialized metabolic systems in plants and other organisms, we devise novel biosynthetic strategies that provide sustainable access to high-value natural products of medicinal or industrial significance. Inspired by the evolutionary principles underlying natural metabolic systems, it further expands the chemical space beyond what nature offers. Leveraging ancient wisdom distilled into the world’s traditional herbal medicines and a deep knowledge base of modern disease biology, it develops nature-inspired new medicines for treating human diseases.

Funding History

August 2018$2.0M
April 2019$3.0M
October 2020$10.0M

Management

Founder

Tian Xu

Chief of Staff and Senior Director of Business Development

Kevin O’Driscoll

Chief Business Officer

Jamie Jones

Chief Medical Officer

Holly Schachner

Founder

Jing-Ke Weng

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo